Transplantation of cell suspension with microneedling in the treatment of vitiligo

Transplantation of autologous melanocyte and keratinocyte cells suspention with micro needeling method for treatment of vitiligo

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080901001159N30

Enrollment

Registered

2020-10-23

Start date

2020-04-20

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo. disorders of pigmentation

Interventions

Intervention group: The pigment-free area is first microneedled and then the processed cell suspension is transferred to the desired area and covered with a suitable dressing..

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having no treatment within past 6 months No pregnancy or breast-feeding Have a diagnosis of vitiligo with depigmented patch more than 5 cm despite receiving at least 3 months active treatment No infection at recipient site No history of keloid and or koebner phenomenon No history of active hepatitis the B, C, or AIDS No active uncontrolled chronic systemic disease

Exclusion criteria

Exclusion criteria: Vitiligo patients with active or progressive disease within last 12 months.

Design outcomes

Primary

Measure	Time frame
Repigmentation rate. Timepoint: Before, 1, 3 and 6 months after treatment. Method of measurement: The amount of melanin in the treated areas compared to before treatment using a maxameter device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem Cell Research Center of Tehran University of Medical Sciences

sonazare_63@yahoo.com+98 21 2220 1710

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026